We are thrilled to announce Earl, Max, and Lucas’ sponsorship of a groundbreaking study at the University of Texas’s MD Anderson Cancer Center in Houston, Texas. As a leading cancer center in the US, MD Anderson is at the forefront of cutting-edge research and treatment advancements. This sponsorship is made in loving memory of Maria Winthrop, whose legacy continues to inspire us.

The study, currently underway, aims to measure the impact of diaphragmatic breathing on reducing heart exposure during breast radiation therapy. This groundbreaking research focuses on the potential benefits of specific breathing techniques in the context of breast cancer treatment, an area that has not been extensively studied before.

Leading the study is Dr. Melissa Mitchell, Department of Breast Radiation Oncology, MD Andersen Cancer Center, Houston Tx., an esteemed expert in the field, who brings extensive knowledge and experience to this important research. Additionally, we are proud to collaborate with Dr. Belisa Vranich, a clinical psychologist, leading expert in mental health and fitness and founder of The Breathing Class, who has provided invaluable insights and guidance to patients.

To help illustrate the significance of incorporating breath coaching into treatment plans, we have attached a heartfelt letter from a patient who recently underwent breath coaching with Dr. Vranich. This firsthand account offers a glimpse into the positive impact that such techniques can have on individuals undergoing breast cancer treatment.

At Winthrop Wealth, our commitment to improving women’s breast cancer treatment outcomes is unwavering. By supporting research initiatives like this study, we strive to contribute to the advancement of medical knowledge and ultimately enhance the lives of patients and their loved ones.

We will continue to share updates and progress regarding the study’s findings, as we believe in the power of collective knowledge and collaboration to drive positive change in breast cancer treatment.

Together, let us work towards a future where innovative approaches, compassionate care, and research breakthroughs lead to improved outcomes for all those affected by breast cancer.